Multimodal therapy from stage-II breast cancer.
作者信息
Edelstyn G A, Bates T, Brinkley D, Kitchen G, MacRae K D, Nicol N T, Spittle M, Wheeler T
出版信息
Lancet. 1978 Nov 18;2(8099):1092. doi: 10.1016/s0140-6736(78)91821-4.
PMID:82102
Abstract
摘要
相似文献
1
Multimodal therapy from stage-II breast cancer.II期乳腺癌的多模式治疗
Lancet. 1978 Nov 18;2(8099):1092. doi: 10.1016/s0140-6736(78)91821-4.
2
Multimodal therapy for histological stage-II breast cancer. Multicentre Breast Cancer Chemotherapy Group.组织学II期乳腺癌的多模式治疗。多中心乳腺癌化疗组。
Lancet. 1977 Aug 20;2(8034):396-7.
3
An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Surg Gynecol Obstet. 1974 Jan;138(1):77-80.
4
Adjuvant therapy of stage II, III breast cancer.II期、III期乳腺癌的辅助治疗。
Recent Results Cancer Res. 1978;68:123-8. doi: 10.1007/978-3-642-81332-0_18.
5
Treatment of early breast cancer.早期乳腺癌的治疗
Lancet. 1978 Nov 25;2(8100):1148-9. doi: 10.1016/s0140-6736(78)92300-0.
6
7
Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.晚期乳腺癌的五药联合疗法：影响毒性和反应的因素
Cancer. 1974 Aug;34(2):239-45. doi: 10.1002/1097-0142(197408)34:2<239::aid-cncr2820340202>3.0.co;2-e.
8
Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Cancer. 1982 Mar 1;49(5):835-9. doi: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z.
9
10
Four drug combination cytotoxic chemotherapy following surgery for breast cancer.乳腺癌手术后的四联药物细胞毒性化疗。
Recent Results Cancer Res. 1978;68:109-12. doi: 10.1007/978-3-642-81332-0_15.
引用本文的文献
1
Why join a multicentre breast cancer trial?为什么要参加多中心乳腺癌试验？
Br Med J. 1979 Mar 24;1(6166):817. doi: 10.1136/bmj.1.6166.817.
Zotero 插件